logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Synthetic biology concept oscillates to a new high, Pfizer and Xinhua Pharmaceutical hit the daily limit.

date
16/05/2025
The concept of synthetic biology is booming, Tuo Xin Pharmaceutical hits limit up, New Hua Pharmaceutical hit limit up earlier, Furuida, Rundu Stock, Jindawei, Rayp Bio and others are among the top gainers.
Latest
2 m ago
Cloud Wisdom Technology (01037.HK) entered into a stock transfer agreement with Shenzhen Hongzhen Enterprise Management Consulting.
3 m ago
Yuyin Group's first quarter distribution plan: intends to distribute 0.02 yuan per 10 shares.
3 m ago
Xinhua Insurance increased its holdings in Shanghai Pharmaceuticals (02607.HK) by 248,000 shares, with a price per share of approximately 10.98 Hong Kong dollars.
3 m ago
FIL Limited increased its stake in Samsonite (01910) by 2.0643 million shares at an approximate price of HK$15.50 per share.
4 m ago
Yue'an New Materials (688786.SH) granted 1,875,300 restricted shares to 257 incentive recipients.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.